YCT-529, a groundbreaking hormone-free male contraceptive pill, has successfully completed its first human safety trial, marking a significant advancement in reproductive health. Unlike traditional methods, YCT-529 selectively blocks sperm production without affecting testosterone levels, potentially eliminating common side effects.
